1. Imugene (IMU) - PH's first child. B-Cell technology platform has been de-risked. Very undervalued at current MC. Drug supply deals with Merck KGaA, Pfizer and Merck & Co. Collaborations with Eureka Therapeutics and Celularity. The closest of the three to signing a deal with big pharma. World class management and SAB.
2. Chimeric Therapeutics (CHM) - Early stage. High risk. Has the potential to be bigger and better than IMU. World class management and SAB.
3. Radiopharm Theranostics (RAD) - Not invested and not interested. PH has enough of my $$$ invested in his companies...hahaha
- Forums
- ASX - By Stock
- CHM
- Paul Hopper IP opportunists CHM VS RAD
Paul Hopper IP opportunists CHM VS RAD, page-2
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $19.69M |
Open | High | Low | Value | Volume |
2.4¢ | 2.4¢ | 2.3¢ | $38.83K | 1.684M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 758450 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 189086 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 758450 | 0.022 |
5 | 905500 | 0.021 |
9 | 538350 | 0.020 |
3 | 555000 | 0.019 |
1 | 100000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 189086 | 1 |
0.024 | 544597 | 3 |
0.025 | 597500 | 1 |
0.026 | 1255000 | 3 |
0.027 | 2190000 | 4 |
Last trade - 15.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
2.3¢ |
  |
Change
-0.001 ( 4.17 %) |
|||
Open | High | Low | Volume | ||
2.3¢ | 2.4¢ | 2.3¢ | 1446775 | ||
Last updated 15.42pm 15/05/2024 ? |
Featured News
CHM (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online